What Cancers Benefit Most from Molecular Diagnostics?
Molecular diagnostics has transformed the management of several types of cancer, including:
Lung Cancer: Identification of mutations in genes such as EGFR, ALK, and ROS1 helps guide targeted therapies. Breast Cancer: Testing for HER2 amplification and BRCA1/2 mutations informs treatment decisions and risk assessment. Colorectal Cancer: Detection of KRAS and BRAF mutations aids in selecting appropriate targeted therapies. Melanoma: Identification of BRAF mutations guides the use of BRAF inhibitors.
